Scholar Rock's SMA drug helps weight loss patients on Zepbound retain muscle in phase 2 trial

Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound maintain muscle mass, offering another avenue to reach a key goal for the obesity market.

Jun 18, 2025 - 15:00
 0
Scholar Rock's SMA drug helps weight loss patients on Zepbound retain muscle in phase 2 trial
Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound maintain muscle mass, offering another avenue to reach a key goal for the obesity market.